medigraphic.com
ENGLISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2019, Número 1

<< Anterior Siguiente >>

Rev Invest Clin 2019; 71 (1)


Symptomatic and Asymptomatic Smokers without Airflow Obstruction: A New Clinical Entity?

Hernández-Zenteno RJ, Flores-Trujillo F, Vázquez-Cortés JJ, Espinosa de los Monteros-Sánchez C, Cosío MG
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 64-69
Archivo PDF: 192.81 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cosio MG, Saetta M. Evasion of COPD in smokers: at what price? Eur Respir J. 2012;39:1298-303.

  2. Rodríguez-Roisin R, Han ML, Vestbo J, et al. Chronic respiratory symptoms with normal spirometry: a reliable clinical entity? Am J Respir Crit Care Med. 2017;195:17-22.

  3. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis. 1980;122:265-21.

  4. Hale KA, Ewing SL, Gosnell BA, Niewoehner DE. Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction. Am Rev Respir Dis. 1984;130:716-21.

  5. Maestrelli P, Saetta M, Mapp CE, Fabbri LM. Remodelling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164:S76-80.

  6. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1304-9.

  7. Ballarin A, Bazzan E, Hernández-Zenteno R, et al. Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:233-9.

  8. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822-6.

  9. Corsico A, Milanese M, Baraldo S, et al. Airway hyperresponsiveness: from molecules to bedside selected contribution: small airway morphology and lung function in the transition from normality to chronic airway obstruction. J Appl Physiol. 2003; 95:441-7.

  10. Gao J, Iwamoto H, Koskela J, et al. Characterization of sputum biomarkers for asthma–COPD overlap syndrome. Int J COPD. 2016;11:2457-65.

  11. Jiménez-Ruiz CA, Sobradillo V, Gabriel R, et al. Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study. Bronconeumologia. 2002;38:530-5.

  12. Rosi E, Scano G. Cigarette smoking and dyspnea perception. Tob Induc Dis. 2004;2:35-42.

  13. Yunesian M, Homayoun-Vash J, Asghari F, Foruzanfar MH, Hosein-Poor AR, Farhud D. Smoking-related respiratory symptoms in Tehran: a cross-sectional study. Arch Iran Med. 2008; 11:507-14.

  14. Pillai SG, Grydeland TB, Dirksen A, et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med. 2010;181:353-9.

  15. Regan EA, Lynch DA, Curran-Everett D, et al. A clinical and radiologic disease in smoker with normal spirometry. JAMA Intern Med. 2015;175:1539-49.

  16. Woodruff P, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Eng J Med 2016;374:1811-21.

  17. Dransfield M, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2017; 195:324-30.

  18. Colebatch HJ, Ng CK. Rate of increase in pulmonary distensibility in a longitudinal study of smokers. Thorax 1988;43:175-82.

  19. Ben-Gary H, Sanders A, Strulovici-Barel Y, et al. Risk of COPD with obstruction in active smoker with normal spirometry and reduced diffusion capacity. Eur Respir J. 2015;46:1589-97.

  20. Jetmalani K, Thamrin C, Farah CS, et al. Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry. Respirology. 2018;23:512-8.

  21. Llontop C, Garcia-Quero C, Castro A, et al. Small airway dysfunction in smokers with stable ischemic heart disease. PLoS One. 2017;12:e0182858.

  22. Berger KI, Pradhan DR, Goldring RM, Oppenheimer BW, Rom WN, Sega LN. Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers. ERJ Open Res. 2016; 2:66-2016.

  23. Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J. 2009;34:858-65.

  24. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364:897-906.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Invest Clin. 2019;71

ARTíCULOS SIMILARES

CARGANDO ...